Song Kun-Xiu, Ji Shao-Lin, Zhao Yong-Jie, Zhang Hao-Ran, Ma Rong-Xing, Zhang Jing-Yu, Hu Yong-Cheng
Tianjin Medical University, Tianjin, China.
Department of Hand & Microsurgery, Binzhou Medical University Hospital, Binzhou, Shandong province, China.
Cell Tissue Bank. 2023 Mar;24(1):203-210. doi: 10.1007/s10561-022-10025-5. Epub 2022 Jul 13.
At present, the commonly used allogeneic bone powder in the clinic can be divided into nondemineralized bone matrix and demineralized bone matrix (DBM). Commonly used demineralizers include acids and ethylene diamine tetraacetic acid (EDTA). There may be some diversities between them. Also, the size of the bone particle can affects its cell compatibility and osteogenic ability. We produced different particle sizes i.e., < 75, 75-100, 100-315, 315-450, 450-650, and 650-1000 μm, and treated in three ways (nondemineralized, demineralized by EDTA, and demineralized by HCl). Scanning electron microscopy showed that the surface of the samples in each group was relatively smooth without obvious differences. The results of specific surface area and porosity analysis showed that they were significantly higher in demineralized bone powder than in nondemineralized bone powder, however, there was no significant difference between the two decalcification methods. The content of hydroxyproline in nondemineralized bone powder and EDTA-demineralized bone powder had no statistical difference, while HCl-demineralization had statistical significance compared with the former two, and the content increased with the decrease of particle size. The protein and BMP-2 extracted from HCl demineralized bone powder were significantly higher than that from nondemineralized bone powder and EDTA demineralized bone powder, and there were differences among different particle sizes. These results suggested the importance of demineralization mode and particle size of the allogenic bone powder and provided guidance for the choice of the most appropriate particle size and demineralization mode to be used in tissue bioengineering.
目前,临床上常用的同种异体骨粉可分为非脱矿骨基质和脱矿骨基质(DBM)。常用的脱钙剂包括酸和乙二胺四乙酸(EDTA)。它们之间可能存在一些差异。此外,骨颗粒的大小会影响其细胞相容性和成骨能力。我们制备了不同粒径,即<75、75 - 100、100 - 315、315 - 450、450 - 650和650 - 1000μm的骨粉,并采用三种方式进行处理(非脱矿、EDTA脱矿和HCl脱矿)。扫描电子显微镜显示,每组样品表面相对光滑,无明显差异。比表面积和孔隙率分析结果表明,脱矿骨粉的比表面积和孔隙率显著高于非脱矿骨粉,然而,两种脱钙方法之间无显著差异。非脱矿骨粉和EDTA脱矿骨粉中羟脯氨酸的含量无统计学差异,而HCl脱矿与前两者相比具有统计学意义,且含量随粒径减小而增加。从HCl脱矿骨粉中提取的蛋白质和BMP - 2显著高于非脱矿骨粉和EDTA脱矿骨粉,且不同粒径之间存在差异。这些结果表明同种异体骨粉脱矿方式和粒径的重要性,并为组织生物工程中最合适粒径和脱矿方式的选择提供了指导。